Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need.
Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Virogin is designing a more potent oncolytic virus, expressing optimized payloads to enhance the systemic antitumor immunity in relapsed/refractory cancers.
Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market.
Company Details
- Employees
- 32
- Founded
- -
- Address
- 150-13511 Commerce Pkwy, Richmond,british Columbia V6v 2j8,canada
- Phone
- +86 (755) 33122597
- co****@****gin.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- virogin.com
- Keywords
- oncology, viruses, tumour immunology, cancer, innovation, immunotherapy, biochemistry, r&d, biotechnology, immuno-oncology, clinical trials.
- HQ
- Richmond, British Columbia
Virogin Biotech Questions
Virogin Biotech's helpline number is +86 (755) 33122597
Virogin Biotech's website is virogin.com
Virogin Biotech's LinkedIn profile is https://ca.linkedin.com/company/viroginbiotech
Virogin Biotech has
32 employees.
View email and phone details for 32
employees at Virogin Biotech.
Virogin Biotech's industry is
Biotechnology Research
Virogin Biotech's top competitors are
Qu Biologics Inc.,
Zymeworks Inc.,
Phyton Biotech,
Symvivo Corporation,
Aspect Biosystems,
Signalchem Biotech Inc.,
Oncolytics Biotech Inc.,
Bold Therapeutics Inc.,
Gandeeva Therapeutics,
Abcellera.
Virogin Biotech's support email address is contact@virogin.com
Virogin Biotech's categories are Biotechnology Research
Virogin Biotech's founding year is 2015
